Insider Trading & Ownership of Adjuvant Global Health Technology Fund, L.P.

Location
New York, NY
Summary
The estimated value of insider holdings of Adjuvant Global Health Technology Fund, L.P. is at least $45,367,317 dollars as of 18 Jan 2024. Adjuvant Global Health Technology Fund, L.P. is the 10%+ Owner of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $45.37M.
Signature
Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
All Insider Reports
All Insider Reports

Notify me when Adjuvant Global Health Technology Fund, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Adjuvant Global Health Technology Fund, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ANTX AN2 Therapeutics, Inc. 10%+ Owner $45,367,317 16 Jan 2024

Insider Transactions Reported by Adjuvant Global Health Technology Fund, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.